Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Artículo en Inglés | MEDLINE | ID: mdl-39221785

RESUMEN

BACKGROUND: Serial transverse enteroplasty is used to treat patients with chronic intestinal failure owing to short bowel syndrome. Current literature lacks discussion of its role for other etiologies of intestinal failure and its impact on adult patients' nutrition support needs and quality of life. METHODS: We performed a case series on adults with parenteral nutrition (PN) dependence who underwent serial transverse enteroplasty at Emory University Hospital, a quaternary referral center between 2011 and 2022. Data collected included demographics, operative technique, and preoperative and postoperative PN requirements. A phone survey was administered to evaluate the impact of PN and the operation on quality of life. RESULTS: Ten patients underwent the procedure of interest during the study period. Indications included short bowel syndrome following multiple abdominal operations or intra-abdominal catastrophe and chronic partial bowel obstruction with dysmotility. Bowel length increased by a median of 83%. All patients were discharged home after a median hospital stay of 21 days. At 1-year follow-up, survival was 100%, two (20%) patients fully weaned from PN, three others (30%) reduced PN frequency, and six (60%) decreased their daily parenteral energy requirement. Two additional patients fully weaned from PN by 18 months postoperatively. CONCLUSION: This represents one of the largest case series of serial transverse enteroplasty in adults. Small intestinal length nearly doubled, and PN dependence was reduced in most patients. Given the low morbidity and good quality of life observed in this series, this procedure should be more widely investigated for patients with chronic intestinal failure.

2.
JPEN J Parenter Enteral Nutr ; 44(4): 661-667, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-31456260

RESUMEN

BACKGROUND: The use of central venous catheter (CVC) access for home parenteral nutrition (HPN) is associated with catheter-related bloodstream infections (CRBSIs). There are limited data on the use of ethanol lock therapy (ELT) to prevent CRBSI in adult HPN patients. Our aim was to determine whether the routine institution of ELT decreased the incidence of CRBSI compared with historic controls at Emory University Hospital (EUH) in Atlanta, Georgia, USA. METHODS: EUH medical records of adult HPN patients discharged with a tunneled, silicone CVC on ELT were retrospectively studied during a pre-hoc determined 14-month observation period (n = 87; 13,386 catheter days) and compared with clinically similar HPN patients from the same institution before institution of the ELT protocol for all appropriate patients. The ELT protocol involved instilling 2 mL of 70% ethanol into each catheter lumen daily after the HPN cycle, following initial flushing with normal saline. RESULTS: Only 5 of 87 patients (5.7%) who received ELT were diagnosed with a CRBSI (0.45/1000 catheter days) during observation. We compared these data with our previously published clinically matched patient population from EUH (n = 22) receiving HPN via a silicone CVC without ELT. Of these historical controls, 45.5% were diagnosed with 1 or more CRBSIs (8.7/1000 catheter days) during observation (P < .001 vs the current ELT cohort). CONCLUSIONS: In this retrospective study with historical controls from the same academic center, institution of ELT in adults requiring HPN via a silicone CVC was associated with a marked (19-fold) reduction in CRBSI.


Asunto(s)
Bacteriemia , Infecciones Relacionadas con Catéteres , Etanol , Nutrición Parenteral en el Domicilio , Adulto , Bacteriemia/epidemiología , Bacteriemia/etiología , Bacteriemia/prevención & control , Infecciones Relacionadas con Catéteres/epidemiología , Infecciones Relacionadas con Catéteres/prevención & control , Cateterismo Venoso Central , Catéteres Venosos Centrales/efectos adversos , Femenino , Humanos , Masculino , Nutrición Parenteral en el Domicilio/efectos adversos , Estudios Retrospectivos , Centros de Atención Terciaria
3.
Nutr Clin Pract ; 33(3): 439-446, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28727945

RESUMEN

BACKGROUND: Continuous renal replacement therapy (CRRT) is commonly used to provide renal replacement therapy in the intensive care unit. Limited published data suggest that CRRT may lead to depletion of water-soluble vitamins and trace elements. The goal of this study was to identify the incidence of trace element and vitamin deficiencies in critically ill patients during CRRT. MATERIALS AND METHODS: This study is based on a retrospective chart review of patients who were referred to Emory University Hospital's nutrition support services and had at least 1 serum micronutrient level measured during CRRT (thiamin, pyridoxine, ascorbic acid, folate, zinc, and copper) between April 1, 2009, and June 1, 2012. RESULTS: Seventy-five patients were included in the study. Nine of 56 patients (16%) had below-normal whole blood thiamin concentrations, and 38 of 57 patients (67%) had below-normal serum pyridoxine levels. Serum ascorbic acid and folate deficiencies were identified among 87% (13 of 15) and 33% (3 of 9) of the study patients, respectively. Nine of 24 patients had zinc deficiency (38%), and 41 of 68 patients had copper deficiency (60%). Of the 75 total subjects, 60 patients (80%) had below-normal levels of at least 1 of the micronutrients measured. CONCLUSIONS: The incidence of various micronutrient deficiencies in critically ill patients who required CRRT was higher than previously reported. Prospective studies are needed to determine the impact of CRRT on micronutrient status and the potential clinical and metabolic efficacy of supplementation in the intensive care unit setting.


Asunto(s)
Enfermedad Crítica/terapia , Micronutrientes/sangre , Diálisis Renal , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Ácido Ascórbico/sangre , Índice de Masa Corporal , Cobre/sangre , Cobre/deficiencia , Femenino , Ácido Fólico/sangre , Humanos , Unidades de Cuidados Intensivos , Masculino , Micronutrientes/deficiencia , Persona de Mediana Edad , Piridoxina/sangre , Piridoxina/deficiencia , Terapia de Reemplazo Renal , Estudios Retrospectivos , Tiamina/sangre , Adulto Joven , Zinc/sangre , Zinc/deficiencia
4.
J Clin Gastroenterol ; 48(10): 862-5, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24583748

RESUMEN

Malabsorptive bariatric surgery is rapidly becoming a major cause of copper deficiency given the increasing prevalence of these procedures for morbid obesity. Acquired copper deficiency can present with clinically significant hematologic and neurological manifestations. Although hematologic manifestations of copper deficiency are rapidly reversible, significant neurological improvement after copper supplementation therapy is unusual and many patients remain debilitated and may only experience, at best, stabilization of the neurological manifestations. Here we present a case of an undiagnosed copper deficiency several years after bariatric gastric bypass surgery, in a patient who concomitantly used zinc-containing denture cream for several years, associated with anemia, neutropenia, myelopathy, respiratory failure, and bilateral optic neuropathy, which caused major vision loss. This patient was also a heterozygote carrier of the 5,10-methylenetetrahydrofolate reductase A1298C gene polymorphism, which may affect copper metabolism. Intravenous copper repletion resulted in rapid correction of hematologic indices. However, neurological manifestations, including vision loss responded only modestly to copper supplementation, despite achieving normal blood copper concentrations. Clinicians should consider copper deficiency in patients at risk, as in this case, as a delayed diagnosis can lead to irreversible disability due to neurological manifestations.


Asunto(s)
Anemia/etiología , Cobre/deficiencia , Enfermedades Carenciales/etiología , Derivación Gástrica/efectos adversos , Neutropenia/etiología , Obesidad Mórbida/cirugía , Enfermedades del Nervio Óptico/etiología , Enfermedades de la Médula Espinal/etiología , Anemia/sangre , Anemia/diagnóstico , Anemia/terapia , Cobre/sangre , Cobre/uso terapéutico , Enfermedades Carenciales/sangre , Enfermedades Carenciales/diagnóstico , Enfermedades Carenciales/genética , Enfermedades Carenciales/terapia , Femenino , Humanos , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Metilenotetrahidrofolato Reductasa (NADPH2)/metabolismo , Persona de Mediana Edad , Neutropenia/sangre , Neutropenia/diagnóstico , Neutropenia/terapia , Enfermedades del Nervio Óptico/sangre , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/terapia , Polimorfismo Genético , Factores de Riesgo , Enfermedades de la Médula Espinal/sangre , Enfermedades de la Médula Espinal/diagnóstico , Enfermedades de la Médula Espinal/terapia , Factores de Tiempo , Resultado del Tratamiento
5.
Nutrition ; 29(1): 52-9, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22858199

RESUMEN

OBJECTIVE: Limited data are available on the incidence and risk factors for infection in patients requiring home parenteral nutrition (HPN). METHODS: A retrospective study was conducted in 101 consecutive adults (63 female, 38 male) discharged on HPN from the Emory University Hospital, Atlanta, GA. New bloodstream infections (BSIs) requiring rehospitalization and other infections were evaluated. RESULTS: Most infections (75%) developed during the initial 6 mo after hospital discharge; rates of BSI were particularly high during the first 4 mo. Fifty-six patients (55.4%) developed 102 BSIs (11.5 BSIs/1000 catheter-days). Most BSIs were attributed to gram-positive organisms (46%), including coagulase-negative Staphylococcus, Staphylococcus aureus, Enterococcus species, and others, followed by Candida species (20%) and gram-negative organisms (13%). Twenty-one percent of BSIs were polymicrobial. The BSI incidence rate ratio was significantly increased for patients with mean prehospital discharge blood glucose concentrations in the highest quartile versus the lowest quartile (incidence rate ratio 2.4, P = 0.017). Patients with a peripherally inserted central catheter versus non-peripherally inserted central catheter central venous catheters had significantly higher rates of BSI (P = 0.018). Thirty-nine patients (38.6%) developed 81 non-BSIs, including pneumonia, urinary tract infections, and surgical site infections. Postdischarge PN dextrose, lipid, and total calorie doses were unrelated to BSI but were variably related to the rate of non-BSIs. CONCLUSIONS: Adult patients on HPN exhibit a very high incidence of post-hospital infections. Higher mean blood glucose levels during predischarge hospitalization and the use of peripherally inserted central catheters at discharge are associated with an increased risk of BSI in the postdischarge home setting.


Asunto(s)
Infecciones Relacionadas con Catéteres/etiología , Nutrición Parenteral en el Domicilio/efectos adversos , Sepsis/etiología , Adulto , Anciano , Anciano de 80 o más Años , Infecciones Relacionadas con Catéteres/epidemiología , Infecciones Relacionadas con Catéteres/microbiología , Femenino , Georgia/epidemiología , Hospitalización , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Factores de Riesgo , Sepsis/epidemiología , Sepsis/microbiología
6.
JPEN J Parenter Enteral Nutr ; 35(5): 581-7, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21799191

RESUMEN

BACKGROUND: Home parenteral nutrition (HPN) is lifesaving for children with intestinal failure. Catheter-associated bloodstream infections (CA-BSI) are common in hospitalized patients receiving parenteral nutrition (PN), but data evaluating CA-BSI in children receiving HPN are limited. OBJECTIVE: To determine the incidence and characteristics of CA-BSI in children receiving HPN. METHODS: Medical records of 44 children receiving HPN during a 3-year period were reviewed. End points were CA-BSI during the initial 6 months after discharge. CA-BSI was defined as isolation of pathogens from blood requiring antimicrobial therapy. RESULTS: The primary indication for HPN was short bowel syndrome (46%), and 59 BSI were documented during the initial 6 months of HPN in 29 (66%) children. Of CA-BSI, polymicrobial infections accounted for 52%; gram-positive, 29%; gram-negative, 17%; and fungal, 2%. CA-BSI incidence per 1000 catheter-days was highest during the first month posthospital discharge (72 episodes; 95% confidence interval [CI], 45.4-109.6). CA-BSI incidence density ratio for children receiving HPN for >90 days compared with those receiving HPN for <30 days was 2.2 (P < .05). Logistic regression revealed that Medicaid insurance and age <1 year were associated with increased risk for CA-BSI (odds ratio [OR], 4.4 [95% CI, 1.13-16.99] and 6.6 [1.50-28.49], respectively; P < .05). CONCLUSIONS: The incidence of CA-BSI in children receiving HPN is highest during the first month posthospital discharge. Strategies to address care in the immediate posthospital discharge period may reduce the burden of infectious complications of HPN.


Asunto(s)
Cateterismo Venoso Central/efectos adversos , Nutrición Parenteral en el Domicilio , Sepsis/epidemiología , Síndrome del Intestino Corto/sangre , Síndrome del Intestino Corto/epidemiología , Glucemia/análisis , Preescolar , Determinación de Punto Final , Femenino , Humanos , Incidencia , Lactante , Modelos Logísticos , Masculino , Estudios Retrospectivos , Factores de Riesgo , Sepsis/microbiología , Síndrome del Intestino Corto/etiología , Síndrome del Intestino Corto/microbiología , Sudeste de Estados Unidos/epidemiología
7.
Curr Opin Clin Nutr Metab Care ; 14(1): 75-82, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21076291

RESUMEN

PURPOSE OF REVIEW: Complete parenteral nutrition solutions contain mixed amino acid products providing all nine essential amino acids and a varying composition of nonessential amino acids. Relatively little rigorous comparative efficacy research on altered parenteral nutrition amino acid composition has been published in recent years. RECENT FINDINGS: Limited data from randomized, double-blind, adequately powered clinical trials to define optimal doses of total or individual amino acids in parenteral nutrition are available. An exception is the growing number of studies on the efficacy of glutamine supplementation of parenteral nutrition or given as a single parenteral agent. Parenteral glutamine appears to confer benefit in selected patients; however, additional data to define optimal glutamine dosing and the patient subgroups who may most benefit from this amino acid are needed. Although some promising studies have been published, little data are available in the current era of nutrition support on the clinical efficacy of altered doses of arginine, branched chain amino acids, cysteine, or taurine supplementation of parenteral nutrition. SUMMARY: Despite routine use of parenteral nutrition, surprisingly little clinical efficacy data are available to guide total or specific amino acid dosing in adult and pediatric patients requiring this therapy. This warrants increased attention by the research community and funding agencies to better define optimal amino acid administration strategies in patient subgroups requiring parenteral nutrition.


Asunto(s)
Aminoácidos/uso terapéutico , Soluciones para Nutrición Parenteral/química , Nutrición Parenteral Total , Aminoácidos/administración & dosificación , Glutamina/uso terapéutico , Humanos , Resultado del Tratamiento
8.
Crit Care Nurs Clin North Am ; 22(3): 369-80, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20691387

RESUMEN

Protein-calorie malnutrition is common in end-stage liver disease, irrespective of cause, and adversely affects clinical outcomes. Early diagnosis is important to allow appropriate intervention to prevent malnutrition-associated complications. Correction of nutrient deficiencies through oral supplementation, enteral tube feeding, or parenteral feeding can improve clinical outcomes in this patient population. This article addresses the causes of malnutrition, methods used to assess nutritional status, and treatment strategies in end-stage liver disease.


Asunto(s)
Enfermedad Hepática en Estado Terminal/terapia , Apoyo Nutricional , Enfermedad Hepática en Estado Terminal/fisiopatología , Nutrición Enteral , Humanos , Síndromes de Malabsorción , Micronutrientes/administración & dosificación , Evaluación Nutricional , Estado Nutricional , Nutrición Parenteral , Desnutrición Proteico-Calórica/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA